Arca
Skip to content
Tools
Tools

Stelkast Surpass Acetabular System

Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented. PMA P040051, from Stelkast Company (Mcmurray, PA). Product code MRA, class 3.

As of Nov 19, 2026, P040051 is an FDA PMA held by Stelkast Company, approved on May 12, 2006 after 501 days, with no recalls tied to it in FDA's recall database.

  • Review time: 501 days
  • Supplements: 2
  • Recalls: 0
  • Cited as a predicate by: 1 device

What FDA approved

FDA's approval order statement

Approval for the Stelkast Surpass Acetabular System. The device is indicated for cementless use in primary total hip arthroplasty in skeletally mature individuals with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis.

Pivotal study

The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it
Design
Prospective, multi-center, non-masked historical control clinical trial (TRANSCEND ceramic hip system, P010001)
Enrolled
965
Where
12 sites
Primary endpoint
Implant survivorship at 2 years (primary efficacy); complication rates (primary safety)
Result
Cumulative Kaplan-Meier survivorship 0.9876 (SE 0.0066) at 24 months; no pre-specified success/failure criteria

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Supplements

2 supplements to this PMA
Apr 22, 2011S002Postapproval Study Protocol - OSBNormal 180 Day Track No User Fee
May 8, 2009S001Process Change - Manufacturer/Sterilizer/Packager/Supplier135 Review Track For 30-Day Notice

Record

Type
Original PMA
Received
Dec 27, 2004
Review panel
Orthopedic

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.